Medtronic

erwin_stock.jpg

Q&A U.S. and European Valvular Heart Disease Guidelines: Lessons from Across the Pond

“Good harmony” is the way John P. Erwin III, MD, describes the synergy of the 2021 ESC/EACTS Guidelines for the management of valvular heart disease (VHD) released in August along with the ACC/AHA guidelines that rolled in December 2020.

kort_stock.jpg

Seeking Out Severe Aortic Stenosis: The Low Down on Low Flow-Low Gradient

It’s not uncommon for severe aortic stenosis to go unrecognized, and thus untreated. When the data points to the existence of low-flow, low-gradient aortic stenosis, a diagnosis can be even more challenging.

Expert Panel 2020 Valvular Heart Disease Guidelines: Recommendations on Treatment, TAVR and Decision-making

Expert Panel: 2020 Valvular Heart Disease Guidelines: Recommendations on Treatment, TAVR and Decision-making

Just-released valvular heart disease guidelines favor transcatheter interventions for the right patient and more shared decision-making among heart teams, physicians and severe aortic stenosis patients with an eye toward types of valves and approaches, and lifetime benefits and risks.

Spotlight on TAVR speakers

Spotlight on TAVR: Pivoting to the Low-Risk Population

Learn from four leading cardiologists on the movement of TAVR into this low-risk patient population, how hospitals are increasing awareness among physicians and patients and the importance of connecting patients with heart teams.